Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tinley Beverage Company Inc C.TNY

Alternate Symbol(s):  TNYBF

The Tinley Beverage Company Inc., together with its subsidiaries, manufactures a line of non-alcoholic, cannabis-infused beverages for use in California, United States and in Ontario, Canada. The Company also manufactures cannabis-infused beverages for contract manufacturing clients. It offers terpene and cannabis-infused non-alcoholic Tinley's '27 and Tinley's Tonics products, for distribution to licensed dispensaries and home delivery channels in California. The Beckett's Classics and Beckett's '27 lines of non-alcoholic, terpene-infused non-cannabis versions of these formulations are available in select mainstream food, beverage, and specialty retailers in the United States as well as in select grocery and specialty stores in Canada. Its subsidiaries include Hemplify Inc., Algonquin Springs Beverage Management LLC, Beckett’s Tonics California Inc., Beckett's Tonics Canada Inc., Tinley's Canada Inc., and Lakewood Libations Inc.


CSE:TNY - Post by User

Bullboard Posts
Comment by ryandloron Jul 12, 2017 4:18pm
64 Views
Post# 26461915

RE:RE:RE:RE:RE:news

RE:RE:RE:RE:RE:newsDrops mic...


MadJack1 wrote: I'll respectively disagree, when you say not that new to market anymore I'll assume you are talking about Hemplify which has 3 flavours, 1 of which they have only done one run on.  The other two are about 7 months old give or take and have included a re-formulation on.  I'll agree that sales have not been that impressive but them doing a 100,000 bottling run says something and so does a reward based (stock options) contract with critical mass to sell 3M worth of Hemplify before year end.  That is a far cry from the recent 12K. 

On the T27 side of things, they did a test run, got 800 people nice and toasty and hopefully took away important lessons learned from that event to get into a lab and iron out the kinks on all flavours (Is there 4 or 5...remember under the radar Gin) before January 1, 2018.  They even state it in today's news (finally). 

Their disclosure isn't misleading per se...I would label it vague and not informative enough, hence the reason I wrote about them not providing measurable metrics yesterday.

On the new flavour front, this is what I know:

Hemplify = 3 flavours (berry passion, tropical punch and lemon/lime)
T27 = 4 flavours (rum, amaretto, margarita, whiskey) and maybe Gin (Dark Horse...Snoop)
Hemp Extract Squeeze

I don't think that is outrageous and granted, I'd love to see Hemplify sales continue to increase but it seems as though this is still a phased approach (customer sampling is the primary phase based on the social media stuff I see).  Distribution and scale will come but you need market acceptance and you need to know where your product will sell before you go balls deep. 

T27 sounds like it is in the re-formulation stage and they are lining larger scale up with Jan1,2018.

The Hemp Extract just came out and they have already sold 1000, pretty sure I got an email about that last week at an intro price of $40 and the message stated the regular price is $54.99 for 50 + servings with 'Free' shipping to all 50 states.  That was pleasantly surprising considering if you do the quick math or 40*1000 that is more than 3 times the amount of Hemplify sales for the last quarter. 

If they knock out the T27 formulations come January 1, 2018 we are all in for a wild ride (2.7 billion medical in California means that rec could be 10 times that number).

MJ1



Bullboard Posts